LCM
ESLA icon

Landscape Capital Management’s Estrella Immunopharma ESLA Stock Holding History

Landscape Capital Management’s Portfolio ESLA Stock Details ESLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-50,105
Closed -$516K – 688
2022
Q4 		$516K Buy
50,105
+27,364
+120% +$278K 0.08% 253
2022
Q3 		$229K Buy
22,741
+2,011
+10% +$20.2K 0.03% 570
2022
Q2 		$207K Hold
20,730
– – 0.03% 565
2022
Q1 		$207K Hold
20,730
– – 0.03% 580
2021
Q4 		$205K Buy
20,730
+10,730
+107% +$106K 0.03% 499
2021
Q3 		$99K Buy
+10,000
New +$98.3K 0.01% 754

Other funds holding ESLA

HHGC
Hunting Hill Global Capital New York $129M AUM 17.34% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
RCM
Robinson Capital Management Grosse Pointe Farms, Michigan $239M AUM 0.62% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
SOA
Sea Otter Advisors Miami, Florida $1.78M AUM 2.28% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Landscape Capital Management's ESLA Position: Q1 2023 in Review

Landscape Capital Management sold out of Estrella Immunopharma (ESLA) in Q1 2023, closing a stake of 50,105 shares — an estimated $516K sold.

Landscape Capital Management first reported a position in ESLA in Q3 2021 and held it in 6 quarters. The position peaked at $516K in Q4 2022. 8 funds tracked by Wall St. Rank hold ESLA as of Q1 2023.

  • Landscape Capital Management reported no remaining Estrella Immunopharma position as of Q1 2023 after selling out during the quarter.
  • Landscape Capital Management sold 50,105 Estrella Immunopharma shares in Q1 2023, an estimated $516K.
  • Landscape Capital Management first reported a position in Estrella Immunopharma in Q3 2021 and held it in 6 quarters.
  • Landscape Capital Management's Estrella Immunopharma position peaked at $516K in Q4 2022.
  • 8 funds tracked by Wall St. Rank held Estrella Immunopharma as of Q1 2023.

Based on Landscape Capital Management's 13F filing for Q1 2023, filed 10 May 2023.